Skip to content
Screener

Schering-Plough SGP Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$37.8M+24.8%
Bausch + Lomb logo
Bausch + LombBLCO
$38M+18.8%
HRO
HarrowHROW
$944K+20.7%
EyePoint, Inc. logo
EyePoint, Inc.EYPT
$2.55M+34.4%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$3.17M+47.0%
Sight Sciences, Inc. logo
Sight Sciences, Inc.SGHT
$394K-30.4%

Other financials

Income statement

See full
Operating income-$15.4M-108%
Net income-$13.8M-56.6%
EPS (diluted)-$0.69+82.6%

Balance sheet

See full
Cash & equivalents$238.9M+312%
Total debt$1.6M—
Total equity$250.1M+463%
Total assets$258.4M—

Cash flow

See full
Operating cash flow-$13.5M-65.2%
CapEx$676.0K+312%
Free cash flow-$14.2M-70.0%

Valuation

See full
Market cap$846.2M+1.3%
Enterprise value$608.9M—

Returns & leverage

See full
Return on equity-34.3%—
Debt / equity0×—
Current ratio38×—

Where this comes from

Reported directly by Schering-Plough in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Schering-Plough’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 4:30 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001778922-26-000035

FAQ

What is Schering-Plough's operating lease liabilities (current)?
Schering-Plough (SGP) reported operating lease liabilities (current) of $0 in Q1 2026.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Schering-Plough's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude